2024-04-012025-03-312025-03-31false07859521MMEDS CARE LTD2025-12-03falseiso4217:GBPxbrli:pure078595212024-03-31078595212025-03-31078595212024-04-012025-03-31078595212023-03-31078595212024-03-31078595212023-04-012024-03-3107859521bus:SmallEntities2024-04-012025-03-3107859521bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3107859521bus:FullAccounts2024-04-012025-03-3107859521bus:PrivateLimitedCompanyLtd2024-04-012025-03-3107859521core:WithinOneYear2025-03-3107859521core:AfterOneYear2025-03-3107859521core:WithinOneYear2024-03-3107859521core:AfterOneYear2024-03-3107859521core:ShareCapital2025-03-3107859521core:SharePremium2025-03-3107859521core:RevaluationReserve2025-03-3107859521core:OtherReservesSubtotal2025-03-3107859521core:RetainedEarningsAccumulatedLosses2025-03-3107859521core:ShareCapital2024-03-3107859521core:SharePremium2024-03-3107859521core:RevaluationReserve2024-03-3107859521core:OtherReservesSubtotal2024-03-3107859521core:RetainedEarningsAccumulatedLosses2024-03-3107859521core:LandBuildings2025-03-3107859521core:PlantMachinery2025-03-3107859521core:Vehicles2025-03-3107859521core:FurnitureFittings2025-03-3107859521core:OfficeEquipment2025-03-3107859521core:NetGoodwill2025-03-3107859521core:IntangibleAssetsOtherThanGoodwill2025-03-3107859521core:ListedExchangeTraded2025-03-3107859521core:UnlistedNon-exchangeTraded2025-03-3107859521core:LandBuildings2024-03-3107859521core:PlantMachinery2024-03-3107859521core:Vehicles2024-03-3107859521core:FurnitureFittings2024-03-3107859521core:OfficeEquipment2024-03-3107859521core:NetGoodwill2024-03-3107859521core:IntangibleAssetsOtherThanGoodwill2024-03-3107859521core:ListedExchangeTraded2024-03-3107859521core:UnlistedNon-exchangeTraded2024-03-3107859521core:LandBuildings2024-04-012025-03-3107859521core:PlantMachinery2024-04-012025-03-3107859521core:Vehicles2024-04-012025-03-3107859521core:FurnitureFittings2024-04-012025-03-3107859521core:OfficeEquipment2024-04-012025-03-3107859521core:NetGoodwill2024-04-012025-03-3107859521core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3107859521core:ListedExchangeTraded2024-04-012025-03-3107859521core:UnlistedNon-exchangeTraded2024-04-012025-03-3107859521core:MoreThanFiveYears2024-04-012025-03-3107859521core:Non-currentFinancialInstruments2025-03-3107859521core:Non-currentFinancialInstruments2024-03-3107859521dpl:CostSales2024-04-012025-03-3107859521dpl:DistributionCosts2024-04-012025-03-3107859521core:LandBuildings2024-04-012025-03-3107859521core:PlantMachinery2024-04-012025-03-3107859521core:Vehicles2024-04-012025-03-3107859521core:FurnitureFittings2024-04-012025-03-3107859521core:OfficeEquipment2024-04-012025-03-3107859521dpl:AdministrativeExpenses2024-04-012025-03-3107859521core:NetGoodwill2024-04-012025-03-3107859521core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3107859521dpl:GroupUndertakings2024-04-012025-03-3107859521dpl:ParticipatingInterests2024-04-012025-03-3107859521dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3107859521core:ListedExchangeTraded2024-04-012025-03-3107859521dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3107859521core:UnlistedNon-exchangeTraded2024-04-012025-03-3107859521dpl:CostSales2023-04-012024-03-3107859521dpl:DistributionCosts2023-04-012024-03-3107859521core:LandBuildings2023-04-012024-03-3107859521core:PlantMachinery2023-04-012024-03-3107859521core:Vehicles2023-04-012024-03-3107859521core:FurnitureFittings2023-04-012024-03-3107859521core:OfficeEquipment2023-04-012024-03-3107859521dpl:AdministrativeExpenses2023-04-012024-03-3107859521core:NetGoodwill2023-04-012024-03-3107859521core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3107859521dpl:GroupUndertakings2023-04-012024-03-3107859521dpl:ParticipatingInterests2023-04-012024-03-3107859521dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3107859521core:ListedExchangeTraded2023-04-012024-03-3107859521dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3107859521core:UnlistedNon-exchangeTraded2023-04-012024-03-3107859521core:NetGoodwill2025-03-3107859521core:IntangibleAssetsOtherThanGoodwill2025-03-3107859521core:LandBuildings2025-03-3107859521core:PlantMachinery2025-03-3107859521core:Vehicles2025-03-3107859521core:FurnitureFittings2025-03-3107859521core:OfficeEquipment2025-03-3107859521core:AfterOneYear2025-03-3107859521core:WithinOneYear2025-03-3107859521core:ListedExchangeTraded2025-03-3107859521core:UnlistedNon-exchangeTraded2025-03-3107859521core:ShareCapital2025-03-3107859521core:SharePremium2025-03-3107859521core:RevaluationReserve2025-03-3107859521core:OtherReservesSubtotal2025-03-3107859521core:RetainedEarningsAccumulatedLosses2025-03-3107859521core:NetGoodwill2024-03-3107859521core:IntangibleAssetsOtherThanGoodwill2024-03-3107859521core:LandBuildings2024-03-3107859521core:PlantMachinery2024-03-3107859521core:Vehicles2024-03-3107859521core:FurnitureFittings2024-03-3107859521core:OfficeEquipment2024-03-3107859521core:AfterOneYear2024-03-3107859521core:WithinOneYear2024-03-3107859521core:ListedExchangeTraded2024-03-3107859521core:UnlistedNon-exchangeTraded2024-03-3107859521core:ShareCapital2024-03-3107859521core:SharePremium2024-03-3107859521core:RevaluationReserve2024-03-3107859521core:OtherReservesSubtotal2024-03-3107859521core:RetainedEarningsAccumulatedLosses2024-03-3107859521core:NetGoodwill2023-03-3107859521core:IntangibleAssetsOtherThanGoodwill2023-03-3107859521core:LandBuildings2023-03-3107859521core:PlantMachinery2023-03-3107859521core:Vehicles2023-03-3107859521core:FurnitureFittings2023-03-3107859521core:OfficeEquipment2023-03-3107859521core:AfterOneYear2023-03-3107859521core:WithinOneYear2023-03-3107859521core:ListedExchangeTraded2023-03-3107859521core:UnlistedNon-exchangeTraded2023-03-3107859521core:ShareCapital2023-03-3107859521core:SharePremium2023-03-3107859521core:RevaluationReserve2023-03-3107859521core:OtherReservesSubtotal2023-03-3107859521core:RetainedEarningsAccumulatedLosses2023-03-3107859521core:AfterOneYear2024-04-012025-03-3107859521core:WithinOneYear2024-04-012025-03-3107859521core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3107859521core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3107859521core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3107859521core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3107859521core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3107859521core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3107859521core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3107859521core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3107859521core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3107859521core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3107859521core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3107859521core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3107859521core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3107859521core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3107859521core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3107859521core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3107859521core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3107859521core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3107859521core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3107859521core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3107859521core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3107859521core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3107859521core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3107859521core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3107859521core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3107859521core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3107859521core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3107859521bus:Director12024-04-012025-03-3107859521bus:Director22024-04-012025-03-31

MMEDS CARE LTD

Registered Number
07859521
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

MMEDS CARE LTD
Company Information
for the year from 1 April 2024 to 31 March 2025

Directors

Fullerton, Andrew
Fullerton, Catherine

Registered Address

14 Lansdowne Terrace
Gosforth
NE3 1HN

Registered Number

07859521 (England and Wales)
MMEDS CARE LTD
Balance Sheet as at
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets5265,485268,144
265,485268,144
Current assets
Debtors6238,400297,945
Cash at bank and on hand283,762265,796
522,162563,741
Creditors amounts falling due within one year7(142,298)(190,994)
Net current assets (liabilities)379,864372,747
Total assets less current liabilities645,349640,891
Creditors amounts falling due after one year8-(49,645)
Net assets645,349591,246
Capital and reserves
Called up share capital100100
Profit and loss account645,249591,146
Shareholders' funds645,349591,246
The financial statements were approved and authorised for issue by the Board of Directors on 3 December 2025, and are signed on its behalf by:
Fullerton, Andrew
Director
Registered Company No. 07859521
MMEDS CARE LTD
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
MMEDS Care Ltd is a private company limited by shares and incorporated in England and Wales. Its registered number is: 07859521 Its registered office is: 14 Lansdowne Terrace Gosforth NE3 1HN
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value. The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated. These financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
Revenue from rendering of services
Turnover comprises the fair value of the consideration received or receivable for the provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts. The company recognises revenue when the amount of revenue can be reliably measured, it is probable that future economic benefits will flow to the entity and specific criteria have been met for the delivery of services under prevailing contractual terms.
Operating leases
Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.
Defined contribution pension plan
The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the company pays fixed contributions into a separate entity. Once the contributions have been paid the company has no further payments obligations.The contributions are recognised as expenses when they fall due. Amounts not paid are shown in other creditors in the balance sheet. The assets of the plan are held separately from the company in independently administered funds.
Borrowing costs
Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the Profit and Loss Account over the period of the relevant borrowing. Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges. Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.
Current taxation
Current tax is recognised in profit or loss. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Deferred tax
Deferred income tax is recognised on material temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements. Deferred income tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.
Intangible assets
The intangible asset recognised relates to a purchased Franchise Fee and is capitalised, classified as an asset on the balance sheet and amortised on a straight line basis over its useful economic life. It is reviewed for impairment if events or changes in circumstances indicate that the carrying value may not be recoverable. Amortisation is provided on the intangible asset at the following annual rate so as to write off the cost, less any estimated residual value, over it's useful life - 20% Straight line.
Tangible fixed assets and depreciation
Tangible fixed assets held for the company's own use are stated at cost less accumulated depreciation and accumulated impairment losses. At each balance sheet date, the company reviews the carrying amount of its tangible fixed assets to determine whether there is any indication that any items have suffered an impairment loss. If any such indication exists, the recoverable amount of an asset is estimated in order to determine the extent of the impairment loss. Depreciation is provided at the following annual rates in order to write off the cost or valuation less the estimated residual value of each asset over its estimated useful life as follows:

Straight line (years)
Land and buildings50
Office Equipment5
Trade and other debtors
Trade debtors are amounts due from customers for services performed in the ordinary course of business. Trade debtors are recognised initially at the transaction price. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.
Share capital
Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. Dividend distributions to the company's shareholders are recognised as a liability in the financial statements in the reporting period in which the dividends are declared.
Government grants or assistance
Government grants are recognised within Other operating income. Revenue grants are recognised, under the accruals method, on a systematic basis over the periods in which the related costs are recorded for which the grant is intended to compensate.
2.Average number of employees

20252024
Average number of employees during the year5157
3.Further information regarding the company's income
The results of the company were derived from continuing operations. The company has no recognised gains or losses for the year other than the results shown in the profit and loss account.
4.Intangible assets

Other

Total

££
Cost or valuation
At 01 April 2439,00039,000
At 31 March 2539,00039,000
Amortisation and impairment
At 01 April 2439,00039,000
At 31 March 2539,00039,000
Net book value
At 31 March 25--
At 31 March 24--
5.Tangible fixed assets

Land & buildings

Office Equipment

Total

£££
Cost or valuation
At 01 April 24271,29249,255320,547
Additions-1,4901,490
At 31 March 25271,29250,745322,037
Depreciation and impairment
At 01 April 247,12945,27452,403
Charge for year1,4262,7234,149
At 31 March 258,55547,99756,552
Net book value
At 31 March 25262,7372,748265,485
At 31 March 24264,1633,981268,144
Included within the net book value of land and buildings above is £262,737 (2024 - £264,163) in respect of freehold land and buildings.
6.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables110,599164,294
Other debtors122,712122,712
Prepayments and accrued income5,08910,939
Total238,400297,945
7.Creditors: amounts due within one year

2025

2024

££
Bank borrowings and overdrafts-4,518
Taxation and social security40,77079,789
Other creditors60,82370,616
Accrued liabilities and deferred income40,70536,071
Total142,298190,994
8.Creditors: amounts due after one year

2025

2024

££
Bank borrowings and overdrafts-49,645
Total-49,645
Included in banks loans and overdrafts are the following amounts (repayable by instalments) due after more than five years: £NIL (2024 £29,225) is due after more than five years in respect of a bank loan that was due for repayment by 2034. The interest rate was fixed for the first five years of the loan, then it was set at a variable rate over the banks base rate of interest, for the remaining term. The loan was secured on the freehold land and buildings of the company.
9.Operating lease commitments
At 31 March 2025 , the company had total commitments under non-cancellable operating leases over the remaining life of those leases of £NIL (2024 – £6,550)
10.Directors advances, credits and guarantees
As at 1 April 2024 a loan advance of £90,000 previously made to the directors was brought forward. No further advances or repayments were made during the year, leaving a balance of £90,000 remaining outstanding as at 31 March 2025. The loan has no fixed terms as to repayment or interest.
11.Share capital
100 £1 Ordinary Shares - Allocated, called up and fully paid.